Breakingviews: Cautionary tale for Japan M&A in Ranbaxy fail
Sunday, April 06, 2014 - 02:23
April 7 - Daiichi Sankyo is giving up control of Ranbaxy Laboratories to Sun Pharma for $3.2 billion. Breakingviews' Peter Thal Larsen says it serves as a reminder of what can go wrong in overseas ventures.
▲ Hide Transcript
▶ View Transcript
Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code